Dilon inks sales pact with PenRad

AuntMinnie.com staff writers
Aug 29, 2011

Breast-specific gamma imaging developer Dilon Diagnostics has signed a three-year sales agreement with mammography information systems developer PenRad Technologies.

Under the terms of the pact, Dilon's portfolio now will include the PenRad mammography information system (MIS) and also Volpara, a quantitative breast density assessment tool designed to convert a qualitative breast x-ray image into quantitative data.
Latest in Breast
Medical illustration of breast tissue with highlighted tumor or cancer area shown in red and orange
FDA clears SimBioSys's breast cancer risk software
October 16, 2026
Healthcare professional demonstrating breast biopsy procedure with circular target icon and medical text on purple background
CEM-guided biopsy effective for sampling suspicious breast findings
October 15, 2026
Breast imaging comparison showing mammogram views and ultrasound scan for diagnostic evaluation
Half of false-negative DBT exams are missed cancers
October 5, 2026
Middle-aged woman in light blue shirt sitting on gray couch with hand on chest
EHR data may miss women eligible for lung cancer screening
September 28, 2026
Related Stories
2011 08 24 15 39 30 522 2011 08 25 Shutter Speed Breast Mri
MRI
Shutter-speed MRI more accurate for breast cancer diagnosis
2011 08 09 11 56 38 249 Stanford Breast Coil Image 02 Thumb
MRI
Stanford group shrinks MRI coil for better breast imaging
2011 07 29 08 17 13 510 2011 07 28 Bmj Thumb
Breast
Debate over breast screening to intensify after new BMJ study
2011 07 06 16 04 57 96 Li Mri Breast Thumb
MRI
CE-MRI predicts survival in breast cancer patients after chemo
More in Breast
FDA clears SimBioSys's breast cancer risk software
By AuntMinnie.com staff writers
The cloud-based software is intended as a prognostic indicator of recurrence-free survival.
October 16, 2026
Medical illustration of breast tissue with highlighted tumor or cancer area shown in red and orange
CEM-guided biopsy effective for sampling suspicious breast findings
By Amerigo Allegretto
CEM-guided biopsy yielded malignancy in over one-quarter of cases.
October 15, 2026
Healthcare professional demonstrating breast biopsy procedure with circular target icon and medical text on purple background
Half of false-negative DBT exams are missed cancers
By AuntMinnie.com staff writers
The results may encourage the development of new benchmarks on the causes of false-negative mammograms.
October 5, 2026
Breast imaging comparison showing mammogram views and ultrasound scan for diagnostic evaluation
EHR data may miss women eligible for lung cancer screening
By Amerigo Allegretto
Smoking history may be underestimated in over one-third of lung cancer screening-eligible women identified by self-reporting.
September 28, 2026
Middle-aged woman in light blue shirt sitting on gray couch with hand on chest
Ikonopedia updates breast reporting platform for BI-RADS v2025
By AuntMinnie.com staff writers
The company's structured breast imaging reporting platform now includes updated terminology from BI-RADS v2025.
September 17, 2026
Healthcare professional performing mammography screening on patient using diagnostic imaging equipment
UH-WBI use increased during COVID-19 pandemic
By Amerigo Allegretto
The use of ultra-hypofractionated whole-breast irradiation (UH-WBI) increased by five times during the pandemic.
September 11, 2026
World map with red overlay illustrating COVID-19 pandemic spread across continents
Neighborhood deprivation tied to lower breast cancer screening
By Amerigo Allegretto
Women residing in neighborhoods with high deprivation have lower odds of getting their mammograms.
September 2, 2026
Healthcare professional guiding patient during mammography screening examination
Mammotome expands production of breast biopsy system
By AuntMinnie.com staff writers
The company said it's increasing production to help address a U.S. shortage of stereotactic breast biopsy needles.
September 1, 2026
Medical illustration of breast tissue cross-section showing internal anatomy with inflammation highlighted in red and orange
CureMetrix secures FDA clearance for cmAngio 2.0
By AuntMinnie.com staff writers
The update introduces BAC quantification, age-based BAC percentile scoring compared against a reference library of more than 170,000 studies.
August 17, 2026
Healthcare professional holding portable mammography scanner displaying breast imaging results
Longitudinal DBT could help improve long-term cancer risk prediction
By Amerigo Allegretto
A longitudinal DBT model outperformed other models based on mammography and clinical factors in predicting five-year cancer risk.
August 13, 2026
Grayscale mammography scan showing breast tissue with varying density patterns
AI tools may not meet breast radiologists' expectations in practice
By Amerigo Allegretto
AI tools in breast imaging may have more modest clinical impact on recall and biopsy rates.
August 12, 2026
Businessperson touching a glowing holographic circular interface with digital network visualization
NME breast lesions have high malignancy rate on MRI-guided biopsy
By Amerigo Allegretto
Biopsies from women with a known ipsilateral malignancy have a higher frequency of breast cancer.
August 10, 2026
Axial MRI scan showing bilateral anatomical structures in grayscale cross-sectional view
Page 1 of 585
Next Page